Dioxidin, ointment 5% 30 g

A broad spectrum antimicrobial agent. Active against Proteus vulgaris, Pseudomonas aeruginosa, Klebsiella pneumoniae (Friedlander’s bacillus), Escherichia coli, Shigella dysenteria, Shigella flexneri, Shigella boydii, Shigella sonnei, Salmonella spp., Staphylococcus spp., Streptococcus spp., pathogenic anaerobes (Clostridium perfringens). It acts on bacterial strains that are resistant to other antibacterial drugs, including antibiotics. It has no local irritating effect. Development of drug resistance of bacteria is possible. Treatment of burn and purulent-necrotic wounds promotes quicker cleaning of the wound surface, stimulates reparative regeneration and marginal epithelialization and has a positive effect on the course of the wound process.

When applied externally it is partially absorbed from the wound or burn surface. It penetrates well and quickly into all organs and tissues and is excreted by the kidneys. It does not cumulate.

Indications

Wound and burn infection – superficial and deep purulent wounds of various locations (including the presence of deep purulent cavities – soft tissue abscesses, pelvic cellulitis, postoperative wounds of the urinary and biliary tract, purulent mastitis), long-term non-healing wounds and trophic ulcers, soft tissue phlegmon, infected burns, purulent wounds with osteomyelitis, pustular skin diseases.

Pharmacological effect

Broad-spectrum antimicrobial agent. Active against Proteus vulgaris, Pseudomonas aeruginosa, Klebsiella pneumoniae (Friedlander’s bacillus), Escherichia coli, Shigella dysenteria, Shigella flexneri, Shigella boydii, Shigella sonnei, Salmonella spp., Staphylococcus spp., Streptococcus spp., pathogenic anaerobes (Clostridium perfringens). Acts on strains of bacteria resistant to other antibacterial drugs, including antibiotics. Does not have a local irritating effect. The development of drug resistance in bacteria is possible. Treatment of burn and purulent-necrotic wounds promotes faster cleansing of the wound surface, stimulates reparative regeneration and marginal epithelization, and has a beneficial effect on the course of the wound process.

When used externally, it is partially absorbed from the wound or burn surface. It penetrates well and quickly into all organs and tissues and is excreted by the kidneys. Does not cumulate.

Special instructions

In case of chronic renal failure, the dose is reduced.

Prescribed only when other antimicrobial drugs are ineffective.

Active ingredient

Hydroxymethylquinoxaline dioxide

Composition

Active ingredient:

hydroxymethylquinoxaline dioxide5 mg

Pregnancy

The drug is contraindicated during pregnancy. Use during breastfeeding is possible only after transferring the child to artificial feeding.

Contraindications

Hypersensitivity to the components of the drug, adrenal insufficiency (including a history), pregnancy, breastfeeding, children under 18 years of age.

Side Effects

Local allergic reactions, periwound dermatitis.

Interaction

Cases of interaction or incompatibility with other drugs have not been described.

Overdose

Cases of overdose have not been described.

Storage conditions

In a place protected from light at a temperature not exceeding 15 C. Keep out of the reach of children.

Shelf life

3 years

Manufacturer

Biosynthesis, Russia